Independent. Trusted. Proven.
Expert buy, hold and sell recommendations from our team of analysts.
For our “HOT” stock today, Raymond Chan, Head of Asian Desk, explains why Morgans recommends Light & Wonder (LNW) as a BUY and its 12-month target price.
Forget datacentres. The childcare centre is critically important! Here are 3 direct and 3 indirect investments in this sector.
For the week ending Friday 7 November 2025, FNArena tracked 14 upgrades and seven downgrades for ASX-listed companies from brokers monitored daily.
It’s been a tricky week for stock players with the tailwinds that have been driving share prices to all-time highs starting to face some countervailing headwinds.
Peter Switzer and Paul Rickard talk about the shift back to safety as investors pile into the banks, whether ASX Ltd is worth buying again, how local techs like Xero and TechnologyOne are holding up, and why Goodman Group and data-centre plays could still have long-term upside.
After their big sell-off, are the rare earth miners now in the “buy zone”? When is the Annual Return for an SMSF due for lodgement to the ATO? Are the major brokers bullish on Cochlear? Is there still time to get out of the Westpac Dividend Re-Investment Plan?
In our “HOT” stock article, Michael Gable, Managing Director of Fairmont Equities, explains that Westpac (WBC) is now breaking higher from this range, which means it should continue to trend from here.
If you take profit and hold cash, where do you park it? Here are two cash Exchange Traded Funds to consider when it’s time to take some profits.
What I’ve created today is my Triple B investment portfolio, that is, the Best Business Buys portfolio — driven by the key messages that Warren Buffett has taught us.
For our “HOT” stock today, Raymond Chan, Head of Asian Desk, explains why Morgans has earmarked ResMed (RMD) as ACCUMULATE.
You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.